Latest News, Updates & Breaking Headlines
Who’s To Blame? MP & TN Govts Trade Charges CHENNAI/BHOPAL/NAGPUR: The adulterated cough syrup death toll rose to 23 after two more children died of renal failure Thursday, while police arrested Govindan Ranganathan (75), the owner of Tamil Nadu-based Sresan Pharmaceuticals, which manufactured the Coldrif medicine. The latest victims – Garvik Pawar and Mayank Suryawanshi,…
The TOI correspondent from Washington: The Trump White House has shelved plans to impose tariffs on generic drug imports in a retreat that will come as a relief to Indian pharmaceutical companies, which account for nearly 50 per cent of generic prescriptions in the US. As importantly, it has also calmed millions of Americans who…
A seven member team from Madhya Pradesh have arrested G Ranganathan, the owner of Sresan Pharmaceuticals from Chennai, officials said on Thursday. NEW DELHI: A seven member team from Madhya Pradesh have arrested G Ranganathan, the owner of Sresan Pharmaceuticals from Chennai, officials said on Thursday.The company accused of manufacturing the toxic Coldrif cough syrup…
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma market’s long standing market leader GlaxoSmithKline’s Augmentin, an antibiotic. During September, Mounjaro recorded sales of Rs 80 crore, becoming the second-largest brand in the pharma retail market, latest data culled by TOI from market research firm Pharmatrac…
India and Brazil engaged in talks regarding the expansion of a preferential trade agreement, addressing market accessibility and potential collaboration in pharmaceutical and banking domains, according to an official statement, released on Tuesday, quoted by PTI.The India-Brazil Trade Monitoring Mechanism (TMM) meeting, held locally, facilitated these discussions. The agenda encompassed bilateral trade and investment relationships,…
Emma Walmsley (Photo credit- AP) British drugmaker GlaxoSmithKline (GSK) on Monday (British time) announced that Emma Walmsley will step down as chief executive in January after nearly nine years at the helm, making way for chief commercial officer Luke Miels to take charge.The leadership transition comes at a critical juncture for the pharma giant, which…
NEW DELHI: The Union commerce ministry told a key parliamentary panel Monday that US tariffs on India’s pharma exports will have a limited impact because India largely exports “generic drugs” instead of “patented drugs” that will bear the brunt of the US decision.At a meeting of the Public Accounts Committee, a top commerce ministry official,…
US stocks opened higher on Monday, clawing back some losses from last week, with investors eyeing a key economic report and ongoing political uncertainty over a potential government shutdown. The S&P 500 rose 0.4% in early trading, the Dow Jones Industrial Average edged up 29 points (0.1%), and the Nasdaq composite gained 0.6%, all hovering…
US President Donald Trump‘s announcement of a 100% tariff on imported “branded and patented pharmaceutical products” has rattled the global pharma industry, though Indian generic drug makers are largely expected to remain unaffected for now.Trump, in a post on Truth Social on Thursday, stated: “Starting October 1st, 2025, we will be imposing a 100% Tariff…
NEW DELHI/HYDERABAD: India’s generic companies are likely to continue in business-as-usual mode as US President Donald Trump’s 100% levy on pharmaceuticals is targeted at branded and patented medicines, but it may also prompt some of them to rethink their playbook.Industry experts told TOI that the country’s largest drugmaker Sun Pharma could face headwinds as its…
